• Agency for Health Care Quality and Research: The Agency spent an estimated $1.5 million on research programs for HIV/AIDS (Foster et al., 1999).

REFERENCES

Centers for Disease Control and Prevention (CDC). 1999a. CDC’s HIV/AIDS Prevention Activities. Atlanta: CDC.

Centers for Disease Control and Prevention (CDC). 1999b. Chart: HIV Prevention Funding FY 94–99. Atlanta: CDC.

Centers for Disease Control and Prevention (CDC). 1999c. Provisional Project List by Mission Category for FY 99 CDC HIV/AIDS Budget. Atlanta: CDC.


Food and Drug Administration. 2000. Testimony of Birnkrant D, Egan W, Klein R, and Tabor E, to the Institute of Medicine’s Committee on HIV Prevention Strategies, March 1, 2000, Washington, DC.

Foster S, Gregory A, Niederhausen P, Rapallo D, Westmoreland T. 1999. Federal HIV/AIDS Spending: A Budget Chartbook. Report Prepared for the Kaiser Family Foundation. Washington, DC: Georgetown University Law Center.


Health Resources and Services Administration (HRSA), HIV/AIDS Bureau. 2000. The AIDS Epidemic and the Ryan White CARE Act: Past Progress, Future Challenges. Washington, DC: HRSA.


Kaiser Family Foundation. 2000. Project Description: Medicaid Eligibility Expansion for People with HIV Prior to Disability. Menlo Park, CA: Kaiser Family Foundation.


National Institutes of Health (NIH). 1999. AIDS Research on HIV Prevention: FY 1999 Estimated. Bethesda, MD: NIH.


Office of AIDS Research (OAR), National Institutes of Health. 1999. National Institutes of Health Fiscal Year 2001 Plan for HIV-Related Research. Bethesda, MD: NIH.

Office of AIDS Research (OAR), National Institutes of Health. 2000a. NIH AIDS Research on HIV Prevention: FY99 Estimated. Document prepared for the Committee on HIV Prevention Strategies. (Received in e-mail communication from Judith Auerbach, March 3, 2000.)

Office of AIDS Research (OAR), National Institutes of Health. 2000b. OAR Prevention Science Initiative Awards by Priority Areas (FY97–FY99). Document prepared for the Committee on HIV Prevention Strategies. (Received in e-mail communication from Judith Auerbach, March 3, 2000.)


Substance Abuse and Mental Health Services Administration (SAMHSA). 1999. SAMHSA/ CSAT Fact Sheet on the HIV Set-Aside of the Substance Abuse Prevention and Treatment Block Grant. Washington, DC: SAMHSA.

Substance Abuse and Mental Health Services Administration (SAMHSA). 2000a. “HIV Designated States” Fiscal Year Obligations, Substance Abuse Prevention and Treatment Block Grant. Washington, DC: SAMHSA.

Substance Abuse and Mental Health Services Administration (SAMHSA). 2000b. HIV Strategic Plan. Washington, DC: SAMHSA.

Substance Abuse and Mental Health Services Administration (SAMHSA). 2000c. Targeted Capacity Expansion Program for Substance Abuse Treatment and HIV/AIDS Services. Washington, DC: SAMHSA.


United States General Accounting Office (GAO) 2000. Drug Abuse Treatment: Efforts Under Way to Determine Effectiveness of State Programs (GAO/HEHS-00-50). Washington, DC: GAO.


Westmoreland T. 1999. Medicaid and HIV/AIDS Policy: A Basic Primer. Report Prepared for the Kaiser Family Foundation. Washington, DC: Federal Legislation Clinic, Georgetown University Law Center.



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement